Inventor
RADER CHRISTOPH
US26 patents
⚠️ This page may combine multiple inventors who share the name “RADER CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RADER CHRISTOPH
5 patentsUS9316646B2Apr 19, 2016
Anti-human ROR1 antibodies
RADER CHRISTOPH45 citations93
US9273136B2Mar 1, 2016
Fully human anti-human NKG2D monoclonal antibodies
RADER CHRISTOPH67 citations92
US9758586B2Sep 12, 2017
Chimeric rabbit/human ROR1 antibodies
RADER CHRISTOPH25 citations89
US8916159B2Dec 23, 2014
Selenocysteine mediated hybrid antibody molecules
RADER CHRISTOPH13 citations79
US8877199B2Nov 4, 2014
B cell surface reactive antibodies
RADER CHRISTOPH16 citations77
SCRIPPS RESEARCH INST
4 patentsUS7087409B2Aug 8, 2006
Humanization of murine antibody
SCRIPPS RESEARCH INST1,400 citations99
US6677435B2Jan 13, 2004
Prodrug activation using catalytic antibodies
SCRIPPS RESEARCH INST103 citations97
US11078273B2Aug 3, 2021
ROR2 antibody compositions and related methods
SCRIPPS RESEARCH INST2 citations71
US11197934B2Dec 14, 2021
Dual variable domain immunoconjugates and uses thereof
SCRIPPS RESEARCH INST0 citations55
UNIV PENNSYLVANIA
4 patentsUS10851149B2Dec 1, 2020
Treatment of cancer using GFR α-4 chimeric antigen receptor
UNIV PENNSYLVANIA3 citations72
US11970525B2Apr 30, 2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor
UNIV PENNSYLVANIA0 citations62
US12281167B2Apr 22, 2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)
UNIV PENNSYLVANIA0 citations57
US11802159B2Oct 31, 2023
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)
UNIV PENNSYLVANIA0 citations57